Jeffrey E. Rogers


Related Content

  • The John Marshall Law School, JD, with Distinction, 1976
  • Loyola University Chicago, BA, 1972
  • Illinois

Member, Litigation and Criminal Justice Sections, American Bar Association

Jeff has practiced exclusively in the area of litigation, with particular emphasis in the areas of white collar criminal defense, related regulatory matters, complex commercial matters, and product liability defense. He represents individuals and companies in a wide range of federal and state criminal investigations and prosecutions, including in the areas of healthcare, environmental enforcement, securities, foreign corrupt practice, defense contracting, taxation and banking. Jeff has tried more than 20 jury or bench cases.

As part of his criminal defense and government regulatory practice, he has supervised and conducted numerous corporate internal investigations for closely held and publicly traded companies. He has also counseled officers, owners and in-house counsel as to corporate internal investigations, both in response to actions initiated by law enforcement personnel, and in an effort to self-discover the existence and scope of potential liabilities prior to law enforcement involvement. Jeff also counsels both financial institutions and private investors on due diligence aspects of prospective transactions where government investigation or regulatory issues exist. His civil practice includes the representation of litigants in complex civil lawsuits, including matters involving the civil False Claims Act, and the defense and management of toxic tort claims, including the defense and management of hundreds of asbestos lawsuits for major corporations.

Prior to joining McGuireWoods, Jeff served as an assistant U.S. attorney in the Northern District of Illinois. In that office, he prosecuted individuals and entities for a myriad of offenses, including bribery, political corruption, racketeering, tax violations and various types of fraud. Jeff instructed other assistant U.S. attorneys at the Trial Advocacy and Appellate Advocacy Institutes of the Department of Justice. He received special commendation and special achievement awards from the Department of Justice for his service. Previously, Jeff served as law clerk to the Honorable Harlington Wood, Jr. for the U.S. Court of Appeals for the 7th Circuit.

Jeff has written articles on the Responsible Corporate Officer Doctrine, on the OIG’s Self-Disclosure Protocol for Matthew Bender’s Health Care Monthly, and on various aspects of False Claims Act litigation.

Jeff is also the partner in charge of pro bono matters in the Chicago office, a position he has held for the last five years.

In the News

Jeffrey E Rogers
T: +1 312 750 8686F: +1 312 558 438577 West Wacker Drive
Suite 4100
Chicago, IL 60601-1818

Represent physician group in federal False Claim Act case alleging improper billing practices for surgeries and relationships with medical device company.

Represent physician in criminal investigation alleging large scale conspiracy involving kickbacks in exchange for patient referrals.

Represented company and its owner in federal criminal environmental case. Obtained sentence of probation below designated and government recommended sentencing guideline range.

Represented company and owner in civil Federal False Claims Act case and related criminal case in investigation by U.S. Attorney's Office and Department of Defense regarding allegations of supplying foreign made goods to Air Force in violation of statute requiring provision of domestically made goods. Ended in civil settlement and sentence of probation below designated and government recommended sentencing guideline range.

Obtained dismissal with prejudice for discovery abuse for client large publicly traded company which provides services related to federal student loans in False Claims Act-Qui Tam case alleging improprieties in connection with claims submitted to the federal government.

Represented medical school in Federal False Claims Act investigation relating to billing for services of residents, interfaced with US Attorney's Office to avoid government's intervention, obtained dismissal of False Claims Act Qui Tam case in Federal Court and dismissal of related suit filed as class action in State Court.

Represented former owners of pharmacy company in joint federal and state False Claims Act investigation related to allegations of improper provision of pharmaceuticals to nursing home patients and illegal kickbacks in connection with customer contracts. No prosecution or civil action was initiated.

Represented former general counsel of large publicly traded provider of pharmaceutical services and products in False Claims Act and related criminal investigation involving allegations of illegal purchasing arrangement with manufacturer of pharmaceuticals.

Represented national dialysis chain in Federal False Claims Act investigation that involved billing issues related to drugs for dialysis patients. Negotiated settlements with U.S. Department of Justice and Office of Inspector General of US Department of Health and Human services, including Corporate Integrity Agreement.

Represented several physician practices that received third party subpoenas for documents and depositions in Federal And State False claims Act case against large pharmaceutical company and others alleging kickbacks in connection with the sale and distribution of pharmaceutical product.

Author, "OIG Issues Updated Provider Self-Disclosure Protocol," Bloomberg BNA Health Care Fraud Report , June 12, 2013
Author, "Guilt By Position: Re-Emergence of the RCO Doctrine," Law360, August 14, 2012
Speaker, "Effective Internal Investigations for Healthcare Entities," Healthcare Litigation and Compliance Webinar Series, September 19, 2017
Speaker, "HCP Relationships and Current Enforcement Issues," 9th Annual Pharmaceutical and Medical Device Conference, November 16, 2017
Speaker, "Staying Ahead of the Government: Self-Regulation Strategies for Ensuring Fraud and Abuse Compliance," 14th Annual Business and Legal Issues in Dialysis and Nephrology Symposium, May 19, 2016
Moderator, "Healthcare Investigations & Litigation: Whistleblower Suits to FTC Antitrust Actions and Beyond," 13th Annual Healthcare and Life Sciences Private Equity and Finance Conference, February 24, 2016
Speaker, "Executive Roundtable - Medical Device Industry Update," 7th Annual Medical Device and Life Sciences Conference, November 19, 2015
Speaker, "Role Play on How to Respond When the FBI Executes a Search Warrant," Hot Topics in Antitrust Compliance, McGuireWoods LLP Seminar, October 14, 2015
Speaker, "The Government’s Process for Evaluating Whistleblower Claims and Building Winning Cases," 13th Annual Business and Legal Issues in Dialysis and Nephrology Symposium, April 14, 2015
Speaker, "HCP Relationships, Open Payments and Current Enforcement Issues," 6th Annual Medical Device and Life Sciences Conference, November 18, 2014
Panelist, "Recent Trends and Developments Under the False Claims Act for Healthcare Providers and Medical Device Manufacturers," Healthcare Litigation Conference, McGuireWoods LLP, April 8, 2014
Speaker, "Litigation Topic: Key Considerations in Government," 11th Annual Business and Legal Issues in Dialysis and Nephrology Symposium, May 16, 2013
Speaker, "10 Key Points for the Healthcare Industry," Corporate Integrity Agreements, McGuireWoods Webinar, January 31, 2013
Co-presenter, "Risk and Crisis Management," Medical Design and Manufacturing Conference, February 16, 2012
Speaker, "Defense Perspectives of Environmental Criminal Prosecutions," Chemical Industry Council of Illinois (a trade group of chemical manufacturers and distributors), February 14, 2012
Presenter, "Recent Regulatory Developments and Enforcement Actions Affecting Pharmaceutical and Medical Device Companies," McGuireWoods Webinar, April 3, 2008
Presenter, "Current Developments Affecting Pharmaceutical and Medical Device Sales and Marketing Practices," McGuireWoods Webinar, November 7, 2007
Presenter, "Pharmaceutical and Medical Device Sales Force Compliance Issues Update," McGuireWoods Medical Device Conference, May 15, 2007